Figures & data
Table 1. Carbonic anhydrase inhibitory activity of compounds 7a–f, 8a–f, and 9a–f and the standard sulphonamide inhibitor acetazolamide (AAZ) using a stopped flow CO2 hydrase assay.
Table 2. Calculated selectivity indexes (S.I.s) for inhibition of hCA IX over hCA I and hCA II isoforms for compounds 7c, 7f, 9e, SLC-0111, and AAZ.
Table 3. Calculated selectivity indexes (S.I.s) for inhibition of hCA XII over hCA I and hCA II isoforms for compounds 8a, 8f, SLC-0111, and AAZ.
Zhang Z. Aryl sulfonamide compounds as carbonic anhydrase inhibitors and their therapeutic use. WO 2017004543. Published online 2017. Elbadawi MM, Eldehna WM, Nocentini A, Somaa WR, Al-Rashood ST, Elkaeed EB, El Hassab MA, Abdel-Aziz HA, Supuran CT, Fares M, et al. Development of 4-((3-oxo-3-phenylpropyl)amino)benzenesulfonamide derivatives utilizing tail/dual-tail approaches as novel carbonic anhydrase inhibitors. Eur J Med Chem. 2022;238:114412. Elbadawi MM, Eldehna WM, Nocentini A, Abo-Ashour MF, Elkaeed EB, Abdelgawad MA, Alharbi KS, Abdel-Aziz HA, Supuran CT, Gratteri P, et al. Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities. Eur J Med Chem. 2021;218:113360.